Computer-Aided Molecular Design, Molecular Simulations, Protein Structure and Function, Inhibitor Design, Antiviral Drug Design, Antibacterial Drug Design, Biophysical Studies
Dr. James Briggs' research is focused in the highly interdisciplinary and collaborative area of computational chemistry/biochemistry. He develops and applies computational methods to problems of chemical and biochemical interest. His research falls into two general categories: computer-aided inhibitor design/discovery and computational biophysics. Briggs' main target areas in the inhibitor/ligand area are: Rho kinase 1 (heart disease), PTEN (cancer), PTEN/5HTC2C (addiction control), BCL2 (cancer), gluconeogenesis and glucose uptake (cancer); those for the computational biophysics area include cholera toxin, biofilm control, RNA structure prediction, protein electrostatics and pKa predictions, and identification of protein/enzyme function from structure only.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
John S. Dunn Gulf Coast Consortium for Chemical Genomics
Training Grants
Houston Area Molecular Biophysics Training Program
Computational Cancer Biology Training Program
Research Consortia
Alcohol and Addiction Research
Gulf Coast Cluster for Translational Addiction Science
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.